Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist Read more
Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates Read more
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer Read more
European Commission Approves Pfizer’s HYMPAVZI (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors Read more
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform Read more
Datopotamab Deruxtecan BLA Submitted for Accelerated Approval in the U.S. for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Read more
Nippon Shinyaku and Atsena Therapeutics enter into an Exclusive Strategic Collaboration for ATSN-101 in the U.S. and Japan Read more